fingolimod hydrochloride has been researched along with thermozymocidin in 11 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (thermozymocidin) | Trials (thermozymocidin) | Recent Studies (post-2010) (thermozymocidin) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 267 | 1 | 148 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | thermozymocidin (IC50) |
|---|---|---|---|
| Serine palmitoyltransferase 2 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, T; Kozutsumi, Y; Nakamura, S | 1 |
| Napoli, KL | 1 |
| Fujita, T; Hirose, R; Kohno, T; Kurio, W; Matsumoto, N; Shimizu, T; Uchida, S; Watabe, K; Yanada, K | 1 |
| Takeya, H | 1 |
| Harada, T; Kanekake, H; Nishikido, M | 1 |
| Ciesek, S; Manns, MP; Pietschmann, T; Steinmann, E; Wedemeyer, H | 1 |
| Oberlies, NH; Pearce, CJ; Strader, CR | 1 |
| Yeung, BK | 1 |
| Hogan, EL; Krotkiewski, H; Podbielska, M | 1 |
| Adachi, K; Chiba, K | 1 |
| Chiba, K | 1 |
8 review(s) available for fingolimod hydrochloride and thermozymocidin
| Article | Year |
|---|---|
["Sphingosine pathway": a novel apoptosis inducing pathway].
Topics: Animals; Apoptosis; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Immunosuppressive Agents; Propylene Glycols; Signal Transduction; Sphingosine | 1996 |
The FTY720 story.
Topics: Animals; Clinical Trials as Topic; Drug Combinations; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Propylene Glycols; Sphingosine | 2000 |
[Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclophosphamide; Cyclosporine; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Recombinant Fusion Proteins; Ribonucleosides; Sphingosine | 2006 |
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
Topics: Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Hypocreales; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sphingosine; Structure-Activity Relationship; United States; United States Food and Drug Administration | 2011 |
Natural product drug discovery: the successful optimization of ISP-1 and halichondrin B.
Topics: Biological Products; Drug Discovery; Ethers, Cyclic; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Furans; Ketones; Macrolides; Molecular Structure; Propylene Glycols; Sphingosine; Structure-Activity Relationship | 2011 |
Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.
Topics: Apoptosis; Ceramides; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Humans; Lysophospholipids; Metabolic Networks and Pathways; Multiple Sclerosis; Myelin Sheath; Propylene Glycols; Receptors, G-Protein-Coupled; Serine C-Palmitoyltransferase; Signal Transduction; Sphingolipids; Sphingosine | 2012 |
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Topics: Animals; Drug Discovery; Encephalomyelitis, Autoimmune, Experimental; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocytes; Multiple Sclerosis; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2012 |
Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii.
Topics: Animals; Drug Discovery; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Humans; Hypocreales; Lymphocytes; Multiple Sclerosis; Structure-Activity Relationship | 2020 |
3 other study(ies) available for fingolimod hydrochloride and thermozymocidin
| Article | Year |
|---|---|
Antibody against a novel, myriocin (ISP-I)-based immunosuppressant, FTY720.
Topics: Animals; Antibodies; Antibody Formation; Antibody Specificity; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Immunosuppressive Agents; Propanolamines; Propylene Glycols; Rabbits; Sphingosine | 2000 |
['Vegetable wasps and plant worms' and G-protein-coupled receptors].
Topics: Cordyceps; Depression, Chemical; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation Mediators; Ligands; Lymphocyte Count; Lymphocytes; Lysophospholipids; Phosphorylation; Propylene Glycols; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine | 2004 |
The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Hepacivirus; Propylene Glycols; RNA, Viral; Serine C-Palmitoyltransferase; Sphingosine; Virus Replication | 2008 |